| 1 |
What is the primary function of AI in the medical imaging industry?
|
To improve diagnostic accuracy and patient outcomes |
|
Consistency and Speed:
AI systems can provide consistent results across a large volume of images and can do so at high speeds, enabling quicker decision-making, which is critical in emergency situations. |
Machine Learning and Deep Learning in Medical Imaging. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
Which of the following is a key benefit of AI in radiology noted in the article?
|
Acts as a second medical opinion |
|
AI can quickly identify patterns and anomalies in medical images, facilitating faster review and diagnosis. |
Error Reduction and Diagnostic Support:
Studies on AI in radiology emphasize its role in reducing diagnostic errors and providing additional insight, which improves patient outcomes and supports clinicians.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
What does AI literacy refer to according to the article?
|
Understanding and knowledge of AI technology |
|
It do what it learn. |
Digital Literacy in Healthcare:
In healthcare, AI literacy helps professionals and patients navigate the growing role of AI in diagnostics, treatment planning, and patient management. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
Which factor is NOT listed as influencing the acceptability of AI among healthcare professionals?
|
The color of the AI machines |
|
Healthcare professionals must trust AI systems to rely on them for diagnostic or decision-making support. |
Technology receptiveness:
The openness of healthcare professionals to adopting new technologies is a key factor in the successful acceptance of AI in healthcare. Those who are more receptive to technological innovations are more likely to embrace AI tools.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
What role does social influence play in AI acceptability in healthcare according to the article?
|
Affects healthcare professionals’ decisions to use AI |
|
It made more EZ. |
Cultural and Social Norms:
Broader cultural and social norms within the healthcare field can shape how professionals perceive and accept AI. If AI is seen as a trusted and beneficial tool within the healthcare community, individuals are more likely to embrace it. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
What is a perceived threat regarding AI usage in healthcare settings?
|
Concerns about replacing healthcare professionals |
|
The fear that AI systems could replace human workers. |
Dehumanization of Care:
There is also concern that AI could reduce the personal, human interaction between patients and healthcare providers, which is a key element of effective and compassionate care. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
According to the article, what is essential for increasing AI acceptability among medical professionals?
|
Designing human-centred AI systems |
|
It easy to use. |
Emphasizing Collaboration:
AI should be seen as a tool that enhances the capabilities of healthcare professionals, promoting collaboration rather than competition. This can increase trust and make AI systems more acceptable and integrated into everyday practice.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
What does the 'system usage' category of AI acceptability factors include according to the article?
|
Factors like value proposition and integration with workflows |
|
The focus of this category is on practical considerations that affect how healthcare professionals use AI systems in their work. |
This refers to the perceived benefits of using the AI system, including how it improves clinical efficiency, diagnostic accuracy, and patient outcomes. If healthcare professionals see a clear value in using AI, they are more likely to accept it. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
How does ethicality impact AI acceptability among healthcare professionals?
|
Affects views on AI based on compatibility with professional values |
|
safty first. |
Data Privacy and Confidentiality:
The ethical handling of patient data is a major concern. Healthcare professionals must be assured that AI systems comply with privacy regulations and safeguard patient confidentiality. Any perceived breach of trust or ethical misconduct could hinder AI acceptance. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
What methodological approach did the article emphasize for future AI acceptability studies?
|
Considering user experience and system integration deeply |
|
Understanding how healthcare professionals interact with AI systems. |
User Experience (UX):
Understanding how healthcare professionals interact with AI systems, the ease of use, and how AI can enhance their daily tasks without disrupting their work is critical for fostering acceptance. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
What is the primary objective of using human embryonic stem cells in treating Parkinson’s disease?
|
To replace lost dopamine neurons. |
|
Parkinson's disease is about neuron. |
Regenerate Dopamine-Producing Neurons:
The goal is to use hESCs to generate new dopamine neurons that can replace those lost during the progression of Parkinson's disease, helping to restore the balance of dopamine in the brain and improve motor function. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
Which animal was used to test the STEM-PD product for safety and efficacy?
|
Monkeys |
|
Monkey brain structure are similar to human. |
Monkeys are often used in preclinical trials for neurological diseases like Parkinson's because their brain structure and functions are more similar to humans compared to smaller animals like rats or mice. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
What was the duration of the preclinical safety study in rats mentioned in the article?
|
12 months |
|
For safty. |
The preclinical safety study in rats mentioned in the article lasted for 12 months. This extended duration was necessary to evaluate the long-term safety and potential side effects of the STEM-PD product. A full year of observation ensures that researchers could monitor the effects of the treatment over time, including potential delayed adverse reactions. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
What is the name of the clinical trial phase mentioned for STEM-PD?
|
Phase I/IIa |
|
The clinical trial phase mentioned for STEM-PD is Phase I/IIa. This phase typically combines elements of both Phase I and Phase II trials. |
Phase I focuses on the safety of the treatment, including determining safe dosage levels and monitoring initial side effects in a small group of participants.
Phase IIa involves further safety assessment along with an initial exploration of the efficacy in a larger group of participants. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
How is the STEM-PD product manufactured?
|
Under GMP-compliant conditions |
|
The STEM-PD product is manufactured under GMP-compliant conditions. GMP stands for Good Manufacturing Practice, which is a set of standards and regulations aimed at ensuring the quality, safety, and consistency of products. |
The STEM-PD product is manufactured under GMP-compliant conditions. GMP stands for Good Manufacturing Practice, which is a set of standards and regulations aimed at ensuring the quality, safety, and consistency of products, particularly in the pharmaceutical and biotechnology industries. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
According to the article, what confirmed the safety of the STEM-PD product in rats?
|
There were no adverse effects or tumor formation. |
|
STEM-PD product in rats was confirmed because there were no adverse effects or tumor formation observed during the preclinical study. |
According to the article, the safety of the STEM-PD product in rats was confirmed because there were no adverse effects or tumor formation observed during the preclinical study. This outcome is critical for determining that the treatment is not causing harmful side effects, such as tumor growth, and that it is safe for further clinical development. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
What key finding was noted in the efficacy study of STEM-PD in rats?
|
Transplanted cells reversed motor deficits in rats. |
|
The key finding was that the transplanted cells reversed motor deficits in the rats. |
In the efficacy study of STEM-PD in rats, the key finding was that the transplanted cells reversed motor deficits in the rats. This suggests that the stem cells were able to restore some of the lost brain function, particularly in the areas affected by Parkinson’s disease, such as motor control. This positive result indicates the potential of the STEM-PD product in treating motor symptoms in Parkinson’s disease. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
What specific markers were used to assess the purity of the STEM-PD batch?
|
LMX1A and EN1 |
|
the specific markers used were LMX1A and EN1. |
LMX1A and EN1 are transcription factors that are typically expressed in dopaminergic neurons, making them suitable markers for assessing the purity of dopamine neuron precursors in stem cell preparations. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
What role do growth factors like FGF8b and SHH play in the manufacturing process of STEM-PD?
|
They are used in cell patterning for specific neural fates. |
|
FGF8b and SHH are known to guide the differentiation of stem cells into dopaminergic neurons. |
FGF8b and SHH are known to guide the differentiation of stem cells into dopaminergic neurons, which are required for the treatment's intended purpose. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
What was a key outcome measured in the preclinical trials for efficacy in rats?
|
Recovery of motor function |
|
The rat need to oiled up,+10,000aura,Still water+German Stare+Pakistani Sitting+Nicaraguan Right Hook+English or Spanish+Albanian Edge walk+Adrenaline+Aztec Pushup+Jamaican Smile+Balkan Rage+Phonk+Anger Issues=Those who |
In the preclinical trials for efficacy in rats, a key outcome that was measured was the recovery of motor function. This is because Parkinson's disease, the condition being targeted by STEM-PD, primarily affects motor control due to the loss of dopamine-producing neurons. Therefore, assessing the recovery of motor function in rats was essential to determine the efficacy of the stem cell therapy in restoring movement and alleviating the motor symptoms of Parkinson’s disease.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|